CC
SUPN icon

Cipher Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

Cipher Capital’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$357K Buy
+10,465
New +$312K 0.17% 225

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Cipher Capital's SUPN Position: Q1 2024 in Review

Cipher Capital opened a new position in Supernus Pharmaceuticals (SUPN) in Q1 2024: 10,465 shares worth $357K. The stake represents 0.17% of the portfolio and ranks #225 among its holdings.

250 funds tracked by Wall St. Rank hold SUPN as of Q1 2024.

  • Cipher Capital held 10,465 shares of Supernus Pharmaceuticals worth $357K as of Q1 2024.
  • Supernus Pharmaceuticals was a new Cipher Capital position in Q1 2024.
  • Supernus Pharmaceuticals made up 0.17% of Cipher Capital's portfolio in Q1 2024, its #225 holding.
  • 250 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.